Bionano Genomics Inc. (BNGO) |
|
0.4729 -0.006 (-1.21%)
|
07-08 10:57 |
|
Open: |
0.49 |
Pre. Close: |
0.4787 |
|
High:
|
0.49 |
Low:
|
0.4658 |
|
Volume:
|
2,204,376 |
Market Cap:
|
40M |
|
|
|
|
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets, and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system includes an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.49 - 0.493 |
0.493 - 0.495 |
|
Low:
|
0.445 - 0.447 |
0.447 - 0.449 |
|
Close:
|
0.476 - 0.48 |
0.48 - 0.484 |
|
Technical analysis |
as of: 2020-07-08 10:25:51 AM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.66  One year: 0.76 |
| Support: |
Support1: 0.43 Support2: 0.36 |
| Resistance: |
Resistance1: 0.57 Resistance2: 0.65 |
| Pivot: |
0.48  |
| Moving Average: |
MA(5): 0.50 MA(20): 0.49
MA(100): 0.53 MA(250): 0.99 |
| MACD: |
MACD(12,26): Signal(9): 0.01 |
| Stochastic oscillator: |
%K(14,3): 26.33 %D(3): 34.27 |
| RSI: |
RSI(14): 48.82 |
| 52-week: |
High: 4.70 Low: 0.25 Change(%): -81.8 |
| Average Vol(K): |
3-Month: 1010785 10-Days: 1698673 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.BNGO has closed above bottom band by 43.9%. Bollinger Bands are 51.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to BNGO's normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 08 Jul 2020
Bionano Genomics Inc. (BNGO) last month volatility was 12.48%: Don’t Ignore this Blaring Warning Signal - News Daemon
Wed, 08 Jul 2020
Bionano Genomics, Inc. (BNGO) set up for great things - The News Heater
Tue, 07 Jul 2020
New Insight on Bionano Genomics, Inc. (BNGO) - Stocks Register
Mon, 06 Jul 2020
Gear up for the change! Bionano Genomics Inc. (BNGO) has hit the volume of 22403686 - The InvestChronicle
Mon, 06 Jul 2020
Erratic Trading Showing Unusual Volume in Shares of Bionano Genomics, Inc. (:BNGO) - Pineville
Thu, 02 Jul 2020
Bionano Genomics Inc. (NASDAQ:BNGO) is Gaining Momentum on Earnings Catalyst - The Oracle Dispatch
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NasdaqCM |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
84 |
| Shares Float (M) |
82 |
|
% Held by Insiders
|
10.41 |
|
% Held by Institutions
|
11.26 |
|
Shares Short (K)
|
4,740 |
|
Shares Short P. Month (K)
|
3,640 |
Stock Financials |
|
EPS
|
-1.523 |
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
-0.110 |
|
Profit Margin
|
|
|
Operating Margin
|
-312.90 |
|
Return on Assets (ttm)
|
-75.7 |
|
Return on Equity (ttm)
|
-3919.1 |
|
Qtrly Rev. Growth
|
-38.7 |
|
Gross Profit (p.s.)
|
0.040 |
|
Sales Per Share
|
0.112 |
|
EBITDA (p.s.)
|
-0.337 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-31 |
|
Levered Free Cash Flow (M)
|
-18 |
Stock Valuations |
|
PE Ratio
|
-0.31 |
|
PEG Ratio
|
|
|
Price to Book value
|
-4.31 |
|
Price to Sales
|
4.23 |
|
Price to Cash Flow
|
-1.28 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
